Intrahepatic Cholestasis Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
ABT | D | Abbott Laboratories | 0.16 | |
MIRM | F | Mirum Pharmaceuticals, Inc. | 0.00 |
Related Industries: Biotechnology Medical Devices
Related ETFs - A few ETFs which own one or more of the above listed Intrahepatic Cholestasis stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
IHI | C | iShares U.S. Medical Devices ETF | 16.8 | |
PJP | B | PowerShares Dynamic Pharmaceuticals | 5.49 | |
HART | B | IQ Healthy Hearts ETF | 4.76 | |
VIRS | A | Pacer BioThreat Strategy ETF | 4.53 | |
DIVL | A | Madison Dividend Value ETF | 4.08 |
Compare ETFs
Related Industries:
Biotechnology
Medical Devices
- Intrahepatic Cholestasis
Intrahepatic cholestasis is a condition in which the flow of bile from the liver is blocked or reduced. This can lead to a buildup of bile acids in the liver and other organs, causing symptoms such as itching, jaundice, and dark urine. It can be caused by a variety of conditions, including liver disease, certain medications, and pregnancy. Treatment depends on the underlying cause.
Recent Comments
- TraderMike on Market Recap for Friday, March 8, 2024
- Don_Marat on Market Recap for Friday, March 8, 2024
- TraderMike on Trades of the Week: Feb 12 - Feb 16, 2024
- Cos3 on Trades of the Week: Feb 12 - Feb 16, 2024
- SwingTradeBot on Market Recap for Tuesday, February 27, 2024
From the Blog
Featured Articles